Skip to content
PubMed This is a summary of 72 peer-reviewed journal articles Updated
Neurosurgery

Understanding Medulloblastoma: A Guide for Parents and Caregivers

At a Glance

Medulloblastoma is the most common malignant pediatric brain tumor, starting in the cerebellum. It is categorized into four distinct molecular subgroups (WNT, SHH, Group 3, and Group 4). These subgroups allow doctors to highly personalize treatment using surgery, radiation, and chemotherapy.

The diagnosis of a brain tumor in your child is a life-altering moment. You are likely feeling overwhelmed, scared, and bombarded with medical terminology. This guide is designed to help you understand your child’s diagnosis, the treatment options, and what to expect in the coming months and years.

Medulloblastoma is a fast-growing embryonal tumor—meaning it begins in primitive cells that were meant to develop into mature brain cells—that starts in the cerebellum, the part of the brain responsible for balance and coordination [1]. It is the most common malignant pediatric brain tumor, though it can also affect adults [2].

While this diagnosis is frightening, the medical community has made incredible strides in treating medulloblastoma. Treatment is now highly precise and personalized based on the molecular makeup of the tumor [3].

This guide is broken down into specific topics to help you navigate this journey step by step:

Your child’s care team is your greatest resource. Use the questions provided in each section to guide your conversations and ensure you are an active partner in your child’s care.

Common questions in this guide

What is medulloblastoma?
Medulloblastoma is a fast-growing embryonal brain tumor that starts in the cerebellum, the part of the brain that controls balance and coordination. While it can occasionally occur in adults, it is the most common malignant pediatric brain tumor.
What are the different subgroups of medulloblastoma?
Medulloblastoma is categorized into four main molecular subgroups based on its biology: WNT, SHH, Group 3, and Group 4. Identifying the specific subgroup is critical because it helps doctors personalize and customize your child's treatment plan for the best outcome.
What are the standard treatments for medulloblastoma?
Treatment typically begins with surgery to remove as much of the tumor as safely possible. Following surgery, treatment is customized based on the child's age and tumor subgroup, often involving a combination of highly targeted radiation therapy and chemotherapy.
Who will be involved in my child's medulloblastoma care?
Your child's care will involve a multidisciplinary team to ensure comprehensive treatment. This usually includes neurosurgeons, pediatric oncologists, radiation oncologists, as well as social workers and child life specialists to help your family navigate the process.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who will be the primary point of contact for our family during this process?
  2. 2.Can you connect us with a social worker or child life specialist to help our family cope?
  3. 3.How does this hospital coordinate care between neurosurgery, oncology, and radiation oncology?
  4. 4.Are there any clinical trials our child might be eligible for based on their initial diagnosis?
  5. 5.What is the immediate next step in our child's care plan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (3)
  1. 1

    Arrested development: the dysfunctional life history of medulloblastoma.

    Tao R, Han K, Wu SC, et al.

    Genes & development 2025; (39(1-2)):4-17 doi:10.1101/gad.351936.124.

    PMID: 39231614
  2. 2

    Molecular Proteomic Characterization of a Pediatric Medulloblastoma Xenograft.

    Tsangaris GT, Dimas K, Malamou A, et al.

    Cancer genomics & proteomics 2017; (14(4)):267-275 doi:10.21873/cgp.20037.

    PMID: 28647700
  3. 3

    Spinal Ependymomas: An Updated WHO Classification and a Narrative Review.

    Villanueva-Castro E, Meraz-Soto JM, Hernández-Dehesa IA, et al.

    Cureus 2023; (15(11)):e49086 doi:10.7759/cureus.49086.

    PMID: 38125233

This guide provides a general overview of medulloblastoma for educational purposes only. Always consult your child's pediatric oncology team for specific medical advice, treatment planning, and clinical trial eligibility.

Get notified when new evidence is published on Medulloblastoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.